Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 3 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Javrishvili Eye Microsu… | Sachkhere District Hosp… | I. Zhordanias Sakhelobi… | Hippocrates | Medi |
|---|---|---|---|---|---|
| Total Revenue | 13,863 | 13,603 | 13,145 | — | — |
| Total COGS | -8,354 | -11,913 | -11,167 | — | — |
| Gross Profit | 5,509 | 1,690 | 1,978 | — | — |
| Gross Margin | 39.7% | 12.4% | 15.0% | — | — |
| Total Operating Expenses | -3,255 | -3,855 | -2,927 | — | — |
| EBITDA | 2,254 | -2,016 | -861 | — | — |
| EBITDA Margin | 16.3% | -14.8% | -6.6% | — | — |
| Total D&A | -371 | -1,500 | -184 | — | — |
| EBIT / Operating Income | 1,883 | -3,516 | -1,045 | — | — |
| Total Interest Expense | -490 | — | — | — | — |
| Total Other Income | 142 | 443 | 269 | — | — |
| Profit Before Tax | 1,535 | -3,073 | -776 | — | — |
| Total Income Tax | -179 | 0 | 0 | — | — |
| Net Profit / (Loss) | 1,356 | -3,073 | -776 | — | — |
| Net Margin | 9.8% | -22.6% | -5.9% | — | — |
| Other Operating Income | — | 148 | 88 | — | — |
| Other Comprehensive Income | — | — | 256 | — | — |
| Total Comprehensive Income | — | — | -520 | — | — |
Not every picked company reports every selected year — FY2024: no filing for Medi and Hippocrates. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Javrishvili Eye Microsu… | Healthcare Services | 16.3% | 69th pct | 268 |
| I. Zhordanias Sakhelobi… | Healthcare Services | -6.6% | 17th pct | 268 |
| Sachkhere District Hosp… | Healthcare Services | -14.8% | 10th pct | 268 |
| Hippocrates | Healthcare Services | — | no FY data | 268 |
| Medi | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.